IBEC Director Josep Samitier stars in one of the Associació per a la Divulgació de la Cultura Cientifica (ADICC)’s ‘Càpsules de Ciència’, a series of videos highlighting biomedical and biotechnology researchers in Catalonia. In the video, he explains nanobiotechnology with the submarine on Ronda de Dalt as a backdrop, which represents the way nanodevices can travel through our bodies much like tiny submarines on a rescue mission.
At the end of last year El Periódico covered the Biomaterials for Regenerative Therapies group’s crowdfunding venture, the Dermoglass project, with a full page article and colour photos.
This week’s press release about the Integrative Cell and Tissue Dynamics group’s work published in Nature Materials has appeared online in La Vanguardia, ABC and El Diario.
Josep Samitier, Xavier Fernandez-Busquets, Santiago Marco and Sergio Oller all feature in this half-hour episode of science programme ‘El problema de Gettier’, which is devoted to nanotechnology.
Results from IBEC researchers and their collaborators will pave the way for better and faster wound healing, as well opening new avenues for tissue engineering of skin
A researcher’s paper published in the journal Environmental Microbiology is just one step in the right direction to tackle a major public health issue that he and other experts say could soon be devastating.Microbiologists led by Antonio Juárez at IBEC and their collaborators at the University of Barcelona reveal that a particular genetic element – a plasmid – that confers multiple antibiotic resistance plays a major role in the survival of Salmonella, the cause of typhoid fever in humans.
Last week BTV’s Connexió programme reported on three of the projects which are currently raising funds by crowdfunding under the UPC’s SUMA initiative. One is the Biomaterials for Regenerative Therapies … Read more
In his capacity of Director of HUBc, the Health Campus of Barcelona University, IBEC Director Josep Samitier presided over their first ever International Conference on Healthy Ageing, held in Barcelona last week.
IBEC Director and Head of Nanobioengineering, Josep Samitier, and the head of the joint IBEC/CRESIB unit on Nanomalaria, Xavier Fernández-Busquets, both featured in an article in the Catalan daily newspaper Ara this weekend.
